MYRIAD GENETICS INC (MYGN) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$824.5M

Net Income/Loss (FY2025)

-$365.9M

Total Assets (FY2025)

$706.6M

Total Equity (FY2025)

$368.0M

Cash Flows from Operating Activities (FY2025)

$1.8M

Source: MYRIAD GENETICS INC 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.